Fuzheng Kang-Ai decoction increases the sensitivity of Gefitinib via inducing Non-Small Cell Lung Cancer ferroptosis through AMPK/SLC7A11 pathway
Yueyang Zhao(Guangzhou University of Chinese Medicine), Sumei Wang(Guangzhou University of Chinese Medicine), Qing Tang(Sichuan University), Qichun Zhou(Guangzhou University of Chinese Medicine), Wanyin Wu(Guangzhou University of Chinese Medicine), Xiao-Bing Yang, Shujing Wang(Anhui Medical University), Mengfei Xu(Guangzhou University of Chinese Medicine), Shenghong Qiu(Guangzhou University of Chinese Medicine), Huanmei Lin(Guangzhou University of Chinese Medicine), NanXing Zhong, Yanqing Pang(Guangzhou University of Chinese Medicine)
Cited by 0
Related Papers
Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance
|npj Precision Oncology|2024|535
HOTAIR: An Oncogenic Long Non-Coding RNA in Human Cancer
|Cellular Physiology and Biochemistry|2018|246
Improving Oral Bioavailability of Sorafenib by Optimizing the “Spring” and “Parachute” Based on Molecular Interaction Mechanisms
|Molecular Pharmaceutics|2015|165
Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction
|Pharmaceutical Research|2016|114